JS111 in Patients With Advanced NSCLC Harboring EGFR Mutations
Clinical trial NCT06940401 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06940401
- Sponsor
- Suzhou Junjing BioSciences Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-30
- Primary completion
- 2028-07-30
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.